493 related articles for article (PubMed ID: 24594295)
1. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
Chan JM; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Gibbs RG
Eur J Vasc Endovasc Surg; 2014 May; 47(5):462-9. PubMed ID: 24594295
[TBL] [Abstract][Full Text] [Related]
2. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.
Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ
J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478
[TBL] [Abstract][Full Text] [Related]
3. Development of Molecular Magnetic Resonance Imaging Tools for Risk Stratification of Carotid Atherosclerotic Disease Using Dual-Targeted Microparticles of Iron Oxide.
Chan JMS; Jin PS; Ng M; Garnell J; Ying CW; Tec CT; Bhakoo K
Transl Stroke Res; 2022 Apr; 13(2):245-256. PubMed ID: 34304360
[TBL] [Abstract][Full Text] [Related]
4. Translational Molecular Imaging Tool of Vulnerable Carotid Plaque: Evaluate Effects of Statin Therapy on Plaque Inflammation and American Heart Association-Defined Risk Levels in Cuff-Implanted Apolipoprotein E-Deficient Mice.
Chan JMS; Park SJ; Ng M; Chen WC; Chan WY; Bhakoo K; Chong TT
Transl Stroke Res; 2024 Feb; 15(1):110-126. PubMed ID: 36481841
[TBL] [Abstract][Full Text] [Related]
5. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.
Metz S; Beer AJ; Settles M; Pelisek J; Botnar RM; Rummeny EJ; Heider P
Int J Cardiovasc Imaging; 2011 Jul; 27(6):901-12. PubMed ID: 20972832
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of carotid plaque vulnerability.
Alonso A; Artemis D; Hennerici MG
Cerebrovasc Dis; 2015; 39(1):5-12. PubMed ID: 25547782
[TBL] [Abstract][Full Text] [Related]
7. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
8. Development of Molecular Magnetic Resonance Imaging Tools for Longitudinal Tracking of Carotid Atherosclerotic Disease Using Fast Imaging with Steady-State Precession.
Park SJ; Chan WY; Ng M; Chung YC; Chong TT; Bhakoo K; Chan JMS
Transl Stroke Res; 2023 Jun; 14(3):357-363. PubMed ID: 35856131
[TBL] [Abstract][Full Text] [Related]
9. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
[TBL] [Abstract][Full Text] [Related]
10. Carotid artery plaque assessment using quantitative expansive remodeling evaluation and MRI plaque signal intensity.
Kurosaki Y; Yoshida K; Fukumitsu R; Sadamasa N; Handa A; Chin M; Yamagata S
J Neurosurg; 2016 Mar; 124(3):736-42. PubMed ID: 26361279
[TBL] [Abstract][Full Text] [Related]
11. Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation.
Vöö S; Kwee RM; Sluimer JC; Schreuder FH; Wierts R; Bauwens M; Heeneman S; Cleutjens JP; van Oostenbrugge RJ; Daemen JW; Daemen MJ; Mottaghy FM; Kooi ME
Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27162131
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance detected carotid plaque hemorrhage is associated with inflammatory features in symptomatic carotid plaques.
Altaf N; Akwei S; Auer DP; MacSweeney ST; Lowe J
Ann Vasc Surg; 2013 Jul; 27(5):655-61. PubMed ID: 23540670
[TBL] [Abstract][Full Text] [Related]
13. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
14. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Hamm B; Botnar RM; Makowski MR
Sci Rep; 2019 Sep; 9(1):13827. PubMed ID: 31554825
[TBL] [Abstract][Full Text] [Related]
15. Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque.
Kawahara I; Nakamoto M; Kitagawa N; Tsutsumi K; Nagata I; Morikawa M; Hayashi T
Neurol Med Chir (Tokyo); 2008 Apr; 48(4):157-61; discussion 161-2. PubMed ID: 18434693
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.
Tang TY; Howarth SP; Miller SR; Graves MJ; U-King-Im JM; Li ZY; Walsh SR; Hayes PD; Varty K; Gillard JH
Eur J Vasc Endovasc Surg; 2008 Apr; 35(4):392-8. PubMed ID: 18171628
[TBL] [Abstract][Full Text] [Related]
17. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
[TBL] [Abstract][Full Text] [Related]
18. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI.
Tang T; Howarth SP; Miller SR; Trivedi R; Graves MJ; King-Im JU; Li ZY; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
Stroke; 2006 Sep; 37(9):2266-70. PubMed ID: 16917091
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.
Shindo A; Tanemura H; Yata K; Hamada K; Shibata M; Umeda Y; Asakura F; Toma N; Sakaida H; Fujisawa T; Taki W; Tomimoto H
PLoS One; 2014; 9(6):e100045. PubMed ID: 24936646
[TBL] [Abstract][Full Text] [Related]
20. Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging.
Weinkauf CC; Concha-Moore K; Lindner JR; Marinelli ER; Hadinger KP; Bhattacharjee S; Berman SS; Goshima K; Leon LR; Matsunaga TO; Unger E
J Vasc Surg; 2018 Dec; 68(6S):105S-113S. PubMed ID: 29452833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
